Barak V - Search Results

1

Identification of interleukin-2 in human peripheral blood eosinophils.

Levi-Schaffer F, Barkans J, Newman TM, Ying S, Wakelin M, Hohenstein R, Barak V, Lacy P, Kay AB, Moqbel R. Levi-Schaffer F, et al. Among authors: barak v. Immunology. 1996 Jan;87(1):155-61. Immunology. 1996. PMID: 8666429 Free PMC article.

2

Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones.

Manetti R, Barak V, Piccinni MP, Sampognaro S, Parronchi P, Maggi E, Dinarello CA, Romagnani S. Manetti R, et al. Among authors: barak v. Res Immunol. 1994 Feb;145(2):93-100. doi: 10.1016/s0923-2494(94)80019-7. Res Immunol. 1994. PMID: 8079050

3

Cytokine dysregulation in chronic graft versus host disease.

Barak V, Levi-Schaffer F, Nisman B, Nagler A. Barak V, et al. Leuk Lymphoma. 1995 Mar;17(1-2):169-73. doi: 10.3109/10428199509051718. Leuk Lymphoma. 1995. PMID: 7773155

4

Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.

Levi-Schaffer F, Segal V, Barak V, Rubinchik E, Nagler A. Levi-Schaffer F, et al. Among authors: barak v. Exp Hematol. 1997 Mar;25(3):238-45. Exp Hematol. 1997. PMID: 9091300

5

Constitutive secretion of interleukin 1 by human monocytes.

Treves AJ, Barak V, Tal T, Fuks Z. Treves AJ, et al. Among authors: barak v. Eur J Immunol. 1983 Aug;13(8):647-51. doi: 10.1002/eji.1830130808. Eur J Immunol. 1983. PMID: 6603982

6

Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection.

Kalinkovich A, Engelmann H, Harpaz N, Burstein R, Barak V, Kalickman I, Wallach D, Bentwich Z. Kalinkovich A, et al. Among authors: barak v. Clin Exp Immunol. 1992 Sep;89(3):351-5. doi: 10.1111/j.1365-2249.1992.tb06961.x. Clin Exp Immunol. 1992. PMID: 1325303 Free PMC article.

7

Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20).

Barak V, Treves AJ, Yanai P, Halperin M, Wasserman D, Biran S, Braun S. Barak V, et al. Eur J Immunol. 1986 Nov;16(11):1449-52. doi: 10.1002/eji.1830161122. Eur J Immunol. 1986. PMID: 3490987

8

Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10.

Houri-Haddad Y, Soskolne WA, Halabi A, Barak V, Shapira L. Houri-Haddad Y, et al. Among authors: barak v. Immunology. 2000 Feb;99(2):215-20. doi: 10.1046/j.1365-2567.2000.00965.x. Immunology. 2000. PMID: 10692039 Free PMC article.

9

Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with dacarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response.

Isacson R, Kedar E, Barak V, Gazit Z, Yurim O, Kalichman I, Ben-Bassat H, Biran S, Schlesinger M, Franks CR, et al. Isacson R, et al. Among authors: barak v. Immunol Lett. 1992 Jul;33(2):127-34. doi: 10.1016/0165-2478(92)90036-n. Immunol Lett. 1992. PMID: 1446917 Clinical Trial.

10

In vitro proliferation of macrophage depleted human peripheral blood lymphocytes.

Treves AJ, Barak V, Fuks Z. Treves AJ, et al. Among authors: barak v. Clin Exp Immunol. 1979 Dec;38(3):531-8. Clin Exp Immunol. 1979. PMID: 535185 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters